AfricInvest has invested USD 10.5 million in HewaTele to enhance medical oxygen access across East Africa by establishing a large-scale liquid oxygen facility.
Information on the Target
HewaTele is a prominent medical oxygen provider based in Kenya, dedicated to improving healthcare access through the provision of high-quality oxygen supplies. With a focus on delivering a consistent and affordable supply of medical oxygen, HewaTele plays a crucial role in enhancing the capacity of hospitals and clinics throughout East Africa. The company's commitment to operational excellence ensures that its liquid oxygen meets a purity level of 99.6%, essential for effective medical use.
The recent investment from AfricInvest will enable HewaTele to expand its capabilities, allowing for the construction of a large-scale liquid oxygen facility. This development is expected to significantly enhance the availability of medical oxygen, particularly in remote and underserved communities, ultimately supporting better health outcomes across the region.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Kenya
The healthcare industry in Kenya has been evolving rapidly, with increasing investments aimed at enhancing infrastructure and service delivery. However, access to medical supplies, particularly oxygen, remains a
Similar Deals
Alta Semper → MYDAWA
2023
Ascent Rift Valley Fund II LP → Valley Hospital Limited
2023
Proparco and Ascent Rift Valley Fund II → Diani Beach Hospital Limited
2022
Growth Lending → A & R Care Limited
2025
New Mountain Capital → Smarter Technologies
2025
InvAscent → Apex Hospitals Private Limited
2025
AfricInvest
invested in
HewaTele
in 2025
in a Growth Equity & Expansion Capital deal
Disclosed details
Transaction Size: $11M